BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,568,437 | -47.1% | 41,559 | -36.1% | 0.01% | -46.2% |
| Q2 2023 | $2,965,273 | +2832.5% | 65,085 | +2510.7% | 0.01% | +1200.0% |
| Q1 2023 | $101,116 | -76.1% | 2,493 | -70.0% | 0.00% | -50.0% |
| Q4 2022 | $423,765 | -61.4% | 8,314 | -59.2% | 0.00% | -60.0% |
| Q3 2022 | $1,098,000 | +290.7% | 20,383 | +366.4% | 0.01% | +400.0% |
| Q2 2022 | $281,000 | -93.5% | 4,370 | -92.2% | 0.00% | -93.3% |
| Q1 2022 | $4,351,000 | +73.8% | 56,112 | +92.5% | 0.02% | +200.0% |
| Q4 2021 | $2,503,000 | +7.3% | 29,156 | +0.5% | 0.01% | -16.7% |
| Q3 2021 | $2,332,000 | -81.7% | 29,000 | -81.6% | 0.01% | -78.6% |
| Q2 2021 | $12,717,000 | +693.8% | 157,978 | +731.5% | 0.03% | +600.0% |
| Q1 2021 | $1,602,000 | +0.6% | 19,000 | -4.2% | 0.00% | 0.0% |
| Q4 2020 | $1,592,000 | +4.2% | 19,842 | +4.4% | 0.00% | -63.6% |
| Q3 2020 | $1,528,000 | -6.6% | 19,000 | 0.0% | 0.01% | -15.4% |
| Q2 2020 | $1,636,000 | +8510.5% | 19,000 | +7916.9% | 0.01% | – |
| Q1 2020 | $19,000 | -99.7% | 237 | -99.6% | 0.00% | -100.0% |
| Q4 2019 | $5,493,000 | – | 65,694 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |